在接受牙科手术的患者中,抗血栓治疗的管理
James Curtis1, Daniel P Henderson2, Mehrdad Zarghami3
1Department of Dentistry, Prisma Health Medical Group-Midlands, Columbia, South Carolina, USA.
Journal of thrombosis and haemostasis : JTH
|October 12, 2024
概括
对于牙科手术,抗血栓治疗通常可以继续,特别是对于轻微的牙科手术. 更多的侵入性手术需要仔细评估风险,以平衡出血和凝血风险.
科学领域:
- 牙科 牙科是指牙科的专业.
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 越来越多的抗血栓治疗患者需要牙科手术.
- 在牙科工作期间平衡出血风险与药物变化的血栓栓塞风险至关重要.
- 轻微的牙科手术通常具有较低的出血风险,允许治疗继续.
研究的目的:
- 审查有关管理牙科手术中抗血栓治疗的证据.
- 为周边手术抗血栓药物管理提出一个实际的方法.
- 引导临床医生为服用抗血小板或抗凝药的患者做出决策.
主要方法:
- 对牙科中抗血栓治疗管理的现有证据的审查.
- 分析与牙科干预相关的出血和血栓塞栓风险.
- 开发一种实用的,风险分层的管理方法.
主要成果:
- 轻微的牙科手术允许继续抗血栓治疗,并采取局部止血措施.
- 更多的侵入性手术需要细微的管理,考虑到个别的风险因素.
- 对初级预防患者来说,暂时的中断可能是合理的.
结论:
- 牙科患者的抗血栓治疗管理需要个性化评估.
- 对于轻微的手术,延续通常是可行的,而侵入性手术需要仔细规划.
- 基于证据的指导方针对于优化患者安全至关重要.
相关概念视频
Venous Thrombosis III: Interprofessional Care
3
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
3
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Coronary Artery Disease V: Surgical Management
3
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
3
Anticoagulant Drugs: Low-Molecular-Weight Heparins
633
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
633
Venous Thrombosis IV: Nursing Management
3
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
3
Angina IV: Management
3
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
3


